Why the study?
Does enalaprilat modulate the action of alpha-adrenoceptor antagonists in isolated rat tail arteries?
Does enalaprilat modulate the action of alpha-adrenoceptor antagonists in isolated rat tail arteries?
Enalaprilat potentiates the effects of certain alpha-adrenoceptor antagonists in rat tail arteries, supporting the hypothesis that angiotensin II modulates vascular smooth muscle alpha 1-adrenoceptor function.
Answers are grounded in this paper and cite their sources.
Rat artery findings should not alter alpha-antagonist dosing; leaves open whether angiotensin II modulates human vascular adrenoceptors.
Isolated perfused rat tail artery preparations were used to investigate the effects of the angiotensin converting enzyme inhibitor enalaprilat on the actions of a series of alpha-adrenoceptor antagonists. The agonist used was phenylephrine. 2. Enalaprilat (1 mumol/L) potentiated the competitive alpha 1-adrenoceptor antagonist actions of phentolamine (10-100 nmol/L) and yohimbine (0.3-3.0 mumol/L) as well as the non-competitive antagonist action of phenoxybenzamine (50-100 pmol/L). 3. The competitive alpha 1-adrenoceptor antagonist action of prazosin (1-10 nmol/L) was not affected by enalaprilat. 4. For the competitive alpha 1-adrenoceptor antagonists, including prazosin, there appeared to be an inverse relationship between antagonist potency and the extent of potentiation by enalaprilat. 5. The results support the hypothesis and angiotensin II modulates vascular smooth muscle alpha 1-adrenoceptor function.
No takes yet. Share an insight, caveat, or question.
John F. Marwood (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: